Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This prospective controlled randomized open-label clinical trial is designed to determine the
eradication rate of 7-day levofloxacin, amoxicillin/clavulanate and rabeprazole regimen
compared with 7-day standard triple therapy for adults infected with Helicobacter pylori in
Eastern Taiwan.